(Q35006385)

5 August 2017

1 reference

title

Overtreatment in epilepsy: adverse consequences and mechanisms (English)

1 reference

5 August 2017

1

Emilio Perucca

1 reference

5 August 2017

publication date

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

52

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

25-33

1 reference

Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Anticonvulsant serum levels are useful only if the physician appropriately uses them: an assessment of the impact of providing serum level data to physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

The management of epilepsy in the 1990s. Acquisitions, uncertainties and priorities for future research

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Relapse following discontinuation of antiepileptic drugs: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Carbamazepine toxicity with lamotrigine: pharmacokinetic or pharmacodynamic interaction?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Topiramate titration and tolerability

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Incidence of drug-induced aggravation in benign epilepsy with centrotemporal spikes

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Add-on phenytoin fails to prevent early seizures after surgery for supratentorial brain tumors: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

The Role of Therapeutic Drug Monitoring in Improving the Cost Effectiveness of Anticonvulsant Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Lamotrigine-associated rash: risk/benefit considerations in adults and children

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

New antiepileptic drugs: review on drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Early identification of refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Effectiveness of first antiepileptic drug.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Topiramate enhances the risk of valproate-associated side effects in three children

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Sudden death in epilepsy: a study of incidence in a young cohort with epilepsy and learning difficulty.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

The importance of drug interactions in epilepsy therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

What can we learn from clinical trials of anticonvulsant drugs in epilepsy?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Interpretation of drug levels in acute and chronic disease states

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Antiepileptic drugs as a cause of worsening seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Assessing risk to benefit ratio in antiepileptic drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Monotherapy or polytherapy for epilepsy?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Therapeutic plasma levels of phenytoin, phenobarbital, and carbamazepine: individual variation in relation to seizure frequency and type

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Reduction in polypharmacy for epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Carbamazepine toxicity during combination therapy with levetiracetam: a pharmacodynamic interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

Factors Influencing the Incidence of Lamotrigine-Related Skin Rash

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

If a well-stabilized epileptic patient has a subtherapeutic antiepileptic drug level, should the dose be increased? A randomized prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900182-1

7 January 2021

10.1016/S0920-1211(02)00182-1

Identifiers

DOI

1 reference

5 August 2017

1 reference